168 related articles for article (PubMed ID: 30526159)
1. Accelerating HIV vaccine development using non-human primate models.
Rahman MA; Robert-Guroff M
Expert Rev Vaccines; 2019 Jan; 18(1):61-73. PubMed ID: 30526159
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of AIDS vaccine strategies in nonhuman primates.
Uberla K
Med Microbiol Immunol; 2005 Aug; 194(4):201-6. PubMed ID: 15843997
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
Chea LS; Amara RR
Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
[TBL] [Abstract][Full Text] [Related]
4. Tackling HIV and AIDS: contributions by non-human primate models.
Van Rompay KKA
Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
[TBL] [Abstract][Full Text] [Related]
5. B-Cells and the Use of Non-Human Primates for Evaluation of HIV Vaccine Candidates.
Demberg T; Robert-Guroff M
Curr HIV Res; 2015; 13(6):462-78. PubMed ID: 26206458
[TBL] [Abstract][Full Text] [Related]
6. Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.
Del Prete GQ; Lifson JD; Keele BF
Curr Opin HIV AIDS; 2016 Nov; 11(6):546-554. PubMed ID: 27559710
[TBL] [Abstract][Full Text] [Related]
7. Non-human primate models for AIDS vaccine research.
Hu SL
Curr Drug Targets Infect Disord; 2005 Jun; 5(2):193-201. PubMed ID: 15975024
[TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
10. Adenoviruses as vectors for HIV vaccines.
Gómez-Román VR; Robert-Guroff M
AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567
[TBL] [Abstract][Full Text] [Related]
11. Challenges in mucosal HIV vaccine development: lessons from non-human primate models.
Tuero I; Robert-Guroff M
Viruses; 2014 Aug; 6(8):3129-58. PubMed ID: 25196380
[TBL] [Abstract][Full Text] [Related]
12. Prospects for a Globally Effective HIV-1 Vaccine.
Excler JL; Robb ML; Kim JH
Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S307-18. PubMed ID: 26590431
[TBL] [Abstract][Full Text] [Related]
13. Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.
Huang Y; DiazGranados C; Janes H; Huang Y; deCamp AC; Metch B; Grant S; Sanchez B; Phogat S; Koutsoukos M; Kanesa-Thasan N; Bourguignon P; Collard A; Buchbinder S; Tomaras GD; McElrath J; Gray G; Kublin JG; Corey L; Gilbert PB
Curr Opin Virol; 2016 Apr; 17():57-65. PubMed ID: 26827165
[TBL] [Abstract][Full Text] [Related]
14. New directions for HIV vaccine development from animal models.
McChesney MB; Miller CJ
Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
[TBL] [Abstract][Full Text] [Related]
15. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.
Fouts TR; Bagley K; Prado IJ; Bobb KL; Schwartz JA; Xu R; Zagursky RJ; Egan MA; Eldridge JH; LaBranche CC; Montefiori DC; Le Buanec H; Zagury D; Pal R; Pavlakis GN; Felber BK; Franchini G; Gordon S; Vaccari M; Lewis GK; DeVico AL; Gallo RC
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):E992-9. PubMed ID: 25681373
[TBL] [Abstract][Full Text] [Related]
16. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
Staprans SI; Feinberg MB; Shiver JW; Casimiro DR
Curr Opin HIV AIDS; 2010 Sep; 5(5):377-85. PubMed ID: 20978377
[TBL] [Abstract][Full Text] [Related]
17. HIV vaccine research: the way forward.
Fauci AS; Johnston MI; Dieffenbach CW; Burton DR; Hammer SM; Hoxie JA; Martin M; Overbaugh J; Watkins DI; Mahmoud A; Greene WC
Science; 2008 Jul; 321(5888):530-2. PubMed ID: 18653883
[TBL] [Abstract][Full Text] [Related]
18. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
19. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
[TBL] [Abstract][Full Text] [Related]
20. The role of nonhuman primates in the development of an AIDS vaccine.
Nathanson N; Hirsch VM; Mathieson BJ
AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
